We know patients because
we treat patients
everyday.
Our patient-driven approach sets us apart
Patient Identification and Segmentation
We take the target market needed for trials and lead patients to the trials that fit them the best. Patients sign up for our secure network with information that describes their health the best. We then take this information and find the trials that help both the patient and trials results.
Patient Recruitment and Trial Marketing
We use the most effective forms of marketing that fit our patients needs and behaviors. Social Media, Website, and Search Engines are where advertisements, videos, and testimonials are posted in order to reach the best patients for the trials.
Post Sign-up Patient Organization
Our secure system organizes patient information safely and securely post sign-up, identifying clinical trials for patients.
Meet with our expert team
Current running trials
Allakos
Symptoms
If you experience persistent gastrointestinal symptoms like:
- Abdominal pain Nausea/Vomiting
- Diarrhea
- Early fullness when eating
- Cramping
- Bloating
- Loss of appetite
Who is Eligible
- Females and Males
- Age 18 to 80 years old
- Have a confirmed diagnosis of EG and/or EoD AND/OR have ongoing gastrointestinal symptoms
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Eli-Lilly
Symptoms
When the disease is active, signs and symptoms may include:
- Diarrhea
- Fever
- Fatigue
- Abdominal pain and cramping
- Blood in your stool
- Mouth sores
- Reduced appetite and weight loss
- Pain or drainage near or around the anus due to inflammation from a tunnel into the skin (fistula)
Who is Eligible
- Females and Males
- Age 15 to 80 years old
- Must have a diagnosis of Crohn’s Disease (CD) for at least 3 months prior to baseline
- Must have a confirmed diagnosis of moderate to severe CD
- Must have demonstrated intolerance, loss of response or inadequate response to conventional or to biologic therapy for CD
- If female, meet the contraception recommendations
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Gossamer Bio
Symptoms
Ulcerative colitis symptoms can vary, depending on the severity of inflammation and where it occurs. Signs and symptoms may include:
- Diarrhea, often with blood or pus
- Abdominal pain and cramping
- Rectal pain
- Rectal bleeding — passing small amount of blood with stool
- Urgency to defecate
- Inability to defecate despite urgency
- Weight loss
- Fatigue
- Fever
- In children, failure to grow
Who is Eligible
- Females and Males
- Age 15 years and older
- Adult male and female subjects aged ≥ 18 years at the time of signing the informed consent form (ICF) prior to initiation of any study specific activities/procedures.
- UC diagnosed at least 3 months prior to first dose of investigational product (IP) on Day 1.
- Currently receiving treatment for UC, on a stable dose for at least 2 weeks prior to flexible sigmoidoscopy or colonoscopy, with oral 5-ASA (eg, mesalamine, sulfasalazine) alone or with one of the following oral treatments:
- prednisone ≤ 20 mg/day or equivalent or
- beclomethasone ≤ 5 mg/day or
- budesonide or budesonide multi-matrix (MMX) of ≤ 9 mg/day
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Bridge Biotherapeutics
Symptoms
Ulcerative colitis symptoms can vary, depending on the severity of inflammation and where it occurs. Signs and symptoms may include:
- Diarrhea, often with blood or pus
- Abdominal pain and cramping
- Rectal pain
- Rectal bleeding — passing small amount of blood with stool
- Urgency to defecate
- Inability to defecate despite urgency
- Weight loss
- Fatigue
- Fever
- In children, failure to grow
Who is Eligible
- Females and Males
- Age 18 to 60 years old
- Male or female, of any race, ≥18 and ≤60 years of age.
- Have been diagnosed with active UC for ≥3 months prior to Day 1, as determined by clinical and endoscopic evidence and documented in a histopathology evaluation.
- Have a total Mayo score ≥6, an endoscopic subscore ≥2, rectal bleeding subscore ≥1, and a stool frequency subscore ≥1, regardless of standard of care history.
- Able to comprehend and willing to voluntarily sign an ICF and to abide by the study restrictions.
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Guardant Health
Symptoms
Signs and symptoms of colon cancer include:
- A persistent change in your bowel habits, including diarrhea or constipation or a change in the consistency of your stool
- Rectal bleeding or blood in your stool
- Persistent abdominal discomfort, such as cramps, gas or pain
- A feeling that your bowel doesn’t empty completely
- Weakness or fatigue
- Unexplained weight loss
Who is Eligible
You can be part of ECLIPSE if you:
- Are between the ages of 45-85
- Live in the United States
- Plan to have a screening colonoscopy
- Have not had a screening colonoscopy in the last 10 years
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Prevention Bio
Symptoms
The signs and symptoms of celiac disease can vary greatly and differ in children and adults. Digestive signs and symptoms for adults include:
- Diarrhea
- Fatigue
- Weight loss
- Bloating and gas
- Abdominal pain
- Nausea and vomiting
- Constipation
Who is Eligible
- Male and Female
- Ages 18 to 70 years of age
- A diagnosis of celiac disease by intestinal biopsy
- Following a GFD for at least 12 consecutive months
- Must have detectable (above the lower limit of detection) serum celiac-related antibodies
- Must have human leukocyte antigen DQ (HLA-DQ) typing consistent with celiac disease (DQ2 and/or DQ8)
- Subjects must have had at least one of the following symptoms at least once per week during the month before screening: diarrhea, loose stools, abdominal pain, abdominal cramping, bloating, or gas.
- Body weight between 35 and 120 kg
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Janssen
Symptoms
The signs and symptoms of celiac disease can vary greatly and differ in children and adults. Digestive signs and symptoms for adults include:
- Diarrhea
- Fatigue
- Weight loss
- Bloating and gas
- Abdominal pain
- Nausea and vomiting
- Constipation
Who is Eligible
- Male and Female
- Ages 18 to 75 years of age
- Have a body mass index (BMI) 16 to 45 kilogram per meter square (kg/m^2). Underweight participants (BMI 16 to 18 kg/m^2) may only be included if in the opinion of the investigator a participant was underweight due to active celiac disease and thus, may benefit from therapy but yet not be at significantly increased risk due to severe malabsorption or other conditions
- Physician-diagnosed celiac disease with documented history of biopsy-proven celiac disease
- Self-reported to be on a gluten-free diet (GFD) for at least 11 consecutive months prior to enrollment and have the willingness to continue to adhere to the same GFD while on study
- Willing to take/ingest gluten containing product at specific study timepoints only
- Willing to undergo 2 on-study esophagogastroduodenoscopy (EGD) with biopsies
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Arena Pharmaceuticals
Symptoms
Signs and symptoms include:
- Difficulty swallowing (dysphagia)
- Food getting stuck in the esophagus after swallowing (impaction)
- Chest pain that is often centrally located and does not respond to antacids
- Backflow of undigested food (regurgitation)
Who is Eligible
- Male and Female
- Ages 18 to 65 years of age
- Have histologically active eosinophilic esophagitis (EoE) with an esophageal peak eosinophil count (PEC) of ≥ 15 eosinophils per high powered field (eos/hpf)
- Have dysphagia, defined as solid food going down slowly or getting stuck in the throat with an average frequency of ≥ 2 episodes per week over 2 weeks during the Screening period
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Exact Sciences
Symptoms
Signs and symptoms of colon cancer include:
- A persistent change in your bowel habits, including diarrhea or constipation or a change in the consistency of your stool
- Rectal bleeding or blood in your stool
- Persistent abdominal discomfort, such as cramps, gas or pain
- A feeling that your bowel doesn’t empty completely
- Weakness or fatigue
- Unexplained weight loss
Who is Eligible
- Females and Males
- Age 40 years and older
- Subject is currently enrolled in Exact Sciences Protocol 2019-01 BLUE-C
- Subject is willing and able to provide a blood sample
- Subject is willing and able to sign informed consent.
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Freenome
Symptoms
Signs and symptoms of colon cancer include:
- A persistent change in your bowel habits, including diarrhea or constipation or a change in the consistency of your stool
- Rectal bleeding or blood in your stool
- Persistent abdominal discomfort, such as cramps, gas or pain
- A feeling that your bowel doesn’t empty completely
- Weakness or fatigue
- Unexplained weight loss
Who is Eligible
- Females and Males
- Age 45 to 85 years old
- Willing to undergo a standard-of-care screening colonoscopy
- Able and willing to provide a blood sample
- Able and willing to sign informed consent
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Seres Therapeutics
Symptoms
Mild to moderate infection
- Watery diarrhea three or more times a day for two or more days
- Mild abdominal cramping and tenderness
Severe infection
- Watery diarrhea 10 to 15 times a day
- Abdominal cramping and pain, which may be severe
- Rapid heart rate
- Fever
- Blood or pus in the stool
- Nausea
- Dehydration
- Loss of appetite
- Weight loss
- Swollen abdomen
- Kidney failure
- Increased white blood cell count
Who is Eligible
- Females and Males
- Age 18 years and older
- Previously enrolled in Study SERES-012, had CDI recurrence within 8 weeks after receipt of study drug, and have completed their SERES-012 Week 8 visit.
- Signed informed consent prior to initiation of any study-specific procedure or treatment. The subject must be able to provide written informed consent and understand the potential risks and benefits from study enrollment and treatment.
- The CDI recurrence in Study SERES-012 must have met the protocol definition of ≥ 3 unformed stools per day over 2 consecutive days, a positive C. difficile stool test, and assessment by the investigator that the clinical condition of the subject warranted treatment.
Have us Contact you
Are you interested in this trial? Sign up with your information on our contact sheet and we will contact you. Fill out the required information and we will reach out to you as soon as we can with information about the trial.
Our many years of experience is
the main reason of sucess
Enrolled Patients
Clinical Trials
Participating Sponsors
3675 Warrensville Center Rd
P.O. Box 201936
Cleveland, OH 44120-5200
Email: marketing@advertrial.net
Phone: (216) 387-5898
Having trouble? Find the answer to your query here. Don’t hesitate to contact us!
Reaching patients online and on-the-go
Super responsive
Very easy to customize
Patient-focused
User-Friendly Enrollment